Cortactin underpins CD44-promoted invasion and adhesion of breast cancer cells to bone marrow endothelial cells

A. Hill, S. McFarlane, K. Mulligan, H. Gillespie, J. E. Draffin, A. Trimble, A. Ouhtit, P. G. Johnston, D. P. Harkin, D. McCormick, D. J J Waugh

Research output: Contribution to journalArticle

74 Citations (Scopus)

Abstract

Using a validated tetracycline (tet)-regulated MCF7-founder (MCF7F) expression system to modulate expression of CD44 standard form (CD44s), we report the functional importance of CD44s and that of a novel transcriptional target of hyaluronan (HA)/CD44s signaling, EMS1/cortactin, in underpinning breast cancer metastasis. In functional experiments, tet-regulated induction of CD44s potentiated the migration and invasion of MCF7F cells through HA-supplemented Matrigel. EMS1/cortactin was identified by expression profiling as a novel transcriptional target of HA/CD44 signaling, an association validated by quantitative PCR and immunoblotting experiments in a range of breast cancer cell lines. The mechanistic basis underpinning CD44-promoted transcription of EMS1/cortactin was shown to be dependent upon a NFκB mechanism, since pharmacological inhibition of IκKinase-2 or suppression of p65 Rel A expression attenuated CD44-induced increases in cortactin mRNA transcript levels. Overexpression of a c-myc tagged murine cortactin construct in the weakly invasive, CD44-deficient MCF7F and T47D cells potentiated their invasion. Furthermore, the functional importance of cortactin to CD44s-promoted metastasis was demonstrated by selective suppression of cortactin in CD44-expressing MCF7F-B5 and MDA-MB-231 breast cancer cells using RNAi, which was shown to result in attenuated CD44-promoted invasion and CD44-promoted adhesion to bone marrow endothelial cells (BMECs).

Original languageEnglish
Pages (from-to)6079-6091
Number of pages13
JournalOncogene
Volume25
Issue number45
DOIs
Publication statusPublished - Oct 5 2006

Fingerprint

Cortactin
Bone Marrow Cells
Endothelial Cells
Breast Neoplasms
Hyaluronic Acid
Tetracycline
Neoplasm Metastasis
MCF-7 Cells
RNA Interference
Immunoblotting
Pharmacology
Cell Line
Polymerase Chain Reaction
Messenger RNA

Keywords

  • Breast cancer
  • CD44
  • Cortactin
  • Invasion
  • Metastasis

ASJC Scopus subject areas

  • Molecular Biology
  • Cancer Research
  • Genetics

Cite this

Hill, A., McFarlane, S., Mulligan, K., Gillespie, H., Draffin, J. E., Trimble, A., ... Waugh, D. J. J. (2006). Cortactin underpins CD44-promoted invasion and adhesion of breast cancer cells to bone marrow endothelial cells. Oncogene, 25(45), 6079-6091. https://doi.org/10.1038/sj.onc.1209628

Cortactin underpins CD44-promoted invasion and adhesion of breast cancer cells to bone marrow endothelial cells. / Hill, A.; McFarlane, S.; Mulligan, K.; Gillespie, H.; Draffin, J. E.; Trimble, A.; Ouhtit, A.; Johnston, P. G.; Harkin, D. P.; McCormick, D.; Waugh, D. J J.

In: Oncogene, Vol. 25, No. 45, 05.10.2006, p. 6079-6091.

Research output: Contribution to journalArticle

Hill, A, McFarlane, S, Mulligan, K, Gillespie, H, Draffin, JE, Trimble, A, Ouhtit, A, Johnston, PG, Harkin, DP, McCormick, D & Waugh, DJJ 2006, 'Cortactin underpins CD44-promoted invasion and adhesion of breast cancer cells to bone marrow endothelial cells', Oncogene, vol. 25, no. 45, pp. 6079-6091. https://doi.org/10.1038/sj.onc.1209628
Hill A, McFarlane S, Mulligan K, Gillespie H, Draffin JE, Trimble A et al. Cortactin underpins CD44-promoted invasion and adhesion of breast cancer cells to bone marrow endothelial cells. Oncogene. 2006 Oct 5;25(45):6079-6091. https://doi.org/10.1038/sj.onc.1209628
Hill, A. ; McFarlane, S. ; Mulligan, K. ; Gillespie, H. ; Draffin, J. E. ; Trimble, A. ; Ouhtit, A. ; Johnston, P. G. ; Harkin, D. P. ; McCormick, D. ; Waugh, D. J J. / Cortactin underpins CD44-promoted invasion and adhesion of breast cancer cells to bone marrow endothelial cells. In: Oncogene. 2006 ; Vol. 25, No. 45. pp. 6079-6091.
@article{23e045a33acc41d0b9ba1435fb127f3e,
title = "Cortactin underpins CD44-promoted invasion and adhesion of breast cancer cells to bone marrow endothelial cells",
abstract = "Using a validated tetracycline (tet)-regulated MCF7-founder (MCF7F) expression system to modulate expression of CD44 standard form (CD44s), we report the functional importance of CD44s and that of a novel transcriptional target of hyaluronan (HA)/CD44s signaling, EMS1/cortactin, in underpinning breast cancer metastasis. In functional experiments, tet-regulated induction of CD44s potentiated the migration and invasion of MCF7F cells through HA-supplemented Matrigel. EMS1/cortactin was identified by expression profiling as a novel transcriptional target of HA/CD44 signaling, an association validated by quantitative PCR and immunoblotting experiments in a range of breast cancer cell lines. The mechanistic basis underpinning CD44-promoted transcription of EMS1/cortactin was shown to be dependent upon a NFκB mechanism, since pharmacological inhibition of IκKinase-2 or suppression of p65 Rel A expression attenuated CD44-induced increases in cortactin mRNA transcript levels. Overexpression of a c-myc tagged murine cortactin construct in the weakly invasive, CD44-deficient MCF7F and T47D cells potentiated their invasion. Furthermore, the functional importance of cortactin to CD44s-promoted metastasis was demonstrated by selective suppression of cortactin in CD44-expressing MCF7F-B5 and MDA-MB-231 breast cancer cells using RNAi, which was shown to result in attenuated CD44-promoted invasion and CD44-promoted adhesion to bone marrow endothelial cells (BMECs).",
keywords = "Breast cancer, CD44, Cortactin, Invasion, Metastasis",
author = "A. Hill and S. McFarlane and K. Mulligan and H. Gillespie and Draffin, {J. E.} and A. Trimble and A. Ouhtit and Johnston, {P. G.} and Harkin, {D. P.} and D. McCormick and Waugh, {D. J J}",
year = "2006",
month = "10",
day = "5",
doi = "10.1038/sj.onc.1209628",
language = "English",
volume = "25",
pages = "6079--6091",
journal = "Oncogene",
issn = "0950-9232",
publisher = "Nature Publishing Group",
number = "45",

}

TY - JOUR

T1 - Cortactin underpins CD44-promoted invasion and adhesion of breast cancer cells to bone marrow endothelial cells

AU - Hill, A.

AU - McFarlane, S.

AU - Mulligan, K.

AU - Gillespie, H.

AU - Draffin, J. E.

AU - Trimble, A.

AU - Ouhtit, A.

AU - Johnston, P. G.

AU - Harkin, D. P.

AU - McCormick, D.

AU - Waugh, D. J J

PY - 2006/10/5

Y1 - 2006/10/5

N2 - Using a validated tetracycline (tet)-regulated MCF7-founder (MCF7F) expression system to modulate expression of CD44 standard form (CD44s), we report the functional importance of CD44s and that of a novel transcriptional target of hyaluronan (HA)/CD44s signaling, EMS1/cortactin, in underpinning breast cancer metastasis. In functional experiments, tet-regulated induction of CD44s potentiated the migration and invasion of MCF7F cells through HA-supplemented Matrigel. EMS1/cortactin was identified by expression profiling as a novel transcriptional target of HA/CD44 signaling, an association validated by quantitative PCR and immunoblotting experiments in a range of breast cancer cell lines. The mechanistic basis underpinning CD44-promoted transcription of EMS1/cortactin was shown to be dependent upon a NFκB mechanism, since pharmacological inhibition of IκKinase-2 or suppression of p65 Rel A expression attenuated CD44-induced increases in cortactin mRNA transcript levels. Overexpression of a c-myc tagged murine cortactin construct in the weakly invasive, CD44-deficient MCF7F and T47D cells potentiated their invasion. Furthermore, the functional importance of cortactin to CD44s-promoted metastasis was demonstrated by selective suppression of cortactin in CD44-expressing MCF7F-B5 and MDA-MB-231 breast cancer cells using RNAi, which was shown to result in attenuated CD44-promoted invasion and CD44-promoted adhesion to bone marrow endothelial cells (BMECs).

AB - Using a validated tetracycline (tet)-regulated MCF7-founder (MCF7F) expression system to modulate expression of CD44 standard form (CD44s), we report the functional importance of CD44s and that of a novel transcriptional target of hyaluronan (HA)/CD44s signaling, EMS1/cortactin, in underpinning breast cancer metastasis. In functional experiments, tet-regulated induction of CD44s potentiated the migration and invasion of MCF7F cells through HA-supplemented Matrigel. EMS1/cortactin was identified by expression profiling as a novel transcriptional target of HA/CD44 signaling, an association validated by quantitative PCR and immunoblotting experiments in a range of breast cancer cell lines. The mechanistic basis underpinning CD44-promoted transcription of EMS1/cortactin was shown to be dependent upon a NFκB mechanism, since pharmacological inhibition of IκKinase-2 or suppression of p65 Rel A expression attenuated CD44-induced increases in cortactin mRNA transcript levels. Overexpression of a c-myc tagged murine cortactin construct in the weakly invasive, CD44-deficient MCF7F and T47D cells potentiated their invasion. Furthermore, the functional importance of cortactin to CD44s-promoted metastasis was demonstrated by selective suppression of cortactin in CD44-expressing MCF7F-B5 and MDA-MB-231 breast cancer cells using RNAi, which was shown to result in attenuated CD44-promoted invasion and CD44-promoted adhesion to bone marrow endothelial cells (BMECs).

KW - Breast cancer

KW - CD44

KW - Cortactin

KW - Invasion

KW - Metastasis

UR - http://www.scopus.com/inward/record.url?scp=33749853670&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33749853670&partnerID=8YFLogxK

U2 - 10.1038/sj.onc.1209628

DO - 10.1038/sj.onc.1209628

M3 - Article

C2 - 16652145

AN - SCOPUS:33749853670

VL - 25

SP - 6079

EP - 6091

JO - Oncogene

JF - Oncogene

SN - 0950-9232

IS - 45

ER -